-
-
-
-
-
-
-
AptarGroup acquires Brazil-based oral dosing packaging firm Sommaplast
-
-
-
-
-
-
-
Aptar Pharma acquires clinical trial manufacturing capabilities from Mod3 Pharma
-
-
-
-
-
-
-
AptarGroup (ATR) PT Raised to $185 at Baird
-
-
-
-
-
-
-
Aptar's (ATR) N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

